KORU Medical Systems (NASDAQ:KRMD) Given New $6.00 Price Target at Craig Hallum

KORU Medical Systems (NASDAQ:KRMD) had its target price increased by Craig Hallum from $5.00 to $6.00 in a research report issued on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Craig Hallum’s target price would suggest a potential upside of 46.70% from the stock’s current price.

Several other research analysts have also recently weighed in on the company. Piper Sandler increased their price objective on KORU Medical Systems from $3.00 to $3.50 and gave the stock an “overweight” rating in a research report on Thursday, November 14th. Lake Street Capital upped their price target on shares of KORU Medical Systems from $4.00 to $5.00 and gave the company a “buy” rating in a research note on Tuesday, January 14th. Finally, Canaccord Genuity Group lifted their price objective on shares of KORU Medical Systems from $3.00 to $4.00 and gave the stock a “buy” rating in a research note on Thursday, November 14th. Four research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $4.50.

KORU Medical Systems Price Performance

KORU Medical Systems stock opened at $4.09 on Friday. The company has a market capitalization of $187.49 million, a price-to-earnings ratio of -16.36 and a beta of 0.45. The company has a current ratio of 2.99, a quick ratio of 2.37 and a debt-to-equity ratio of 0.01. KORU Medical Systems has a 12 month low of $1.98 and a 12 month high of $4.60. The stock’s 50 day moving average is $3.82 and its 200-day moving average is $2.97.

Institutional Trading of KORU Medical Systems

Large investors have recently modified their holdings of the stock. XTX Topco Ltd bought a new stake in KORU Medical Systems during the third quarter worth about $34,000. Connor Clark & Lunn Investment Management Ltd. raised its position in shares of KORU Medical Systems by 77.7% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company’s stock valued at $168,000 after buying an additional 26,860 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of KORU Medical Systems by 6.5% during the 3rd quarter. Geode Capital Management LLC now owns 462,128 shares of the company’s stock worth $1,262,000 after acquiring an additional 28,323 shares during the period. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of KORU Medical Systems during the 2nd quarter worth approximately $107,000. Finally, Empire Financial Management Company LLC acquired a new stake in shares of KORU Medical Systems during the 3rd quarter worth approximately $259,000. 58.60% of the stock is owned by institutional investors and hedge funds.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.